The article describes the main psychotherapeutic targets and individual psychological characteristicsof cancer patients with comorbid post-traumatic stress disorder (PTSD), using the example of breast cancer, prostate cancer, and rectal cancer patients in remission following surgery (mastectomy, prostatectomy, and colostomy). The study was carried out at N. N. Petrov Research Institute of Oncology. The experimental group consisted of 40 patients with breast cancer, 32 patients with prostate cancer, and 19 patients with rectal cancer, in accordance with the selection criteria and based on a specialized questionnaire designed to detect symptoms of post-traumatic stress disorder (Trauma Screening Questionnaire). A control group, for comparison, was comprised of 51 women with breast cancer, 53 patients with prostate cancer, and 22 patients with rectal cancer who showed signs of constructively coping with cancer. The assessment of individual psychological characteristics of patients in these nosological groups was carried out using a battery of experimental psychological techniques. In order to enhance the adaptive capacity of the personality in patients with oncological diseases, to prevent the likelihood of developing PTSD, and develop the effectiveness of treatment, the following general psychotherapeutic targets were identified: intrapsychic maladaptive type of response to the disease, excessive fixation on the disease and care during illness; low risk tolerance manifested by patients’ reluctance to act in the absence of reliable guarantees of success; destructive and deficient personality functions; shortage of positive cognitive representations of the world and themselves; destructive guilt associated with the illness and family relationships; excessive desire for autonomy and independence that reduces the possibility of receiving social support.

No abstract

A603analysis was performed on real-world observational data from the years 2010-2013 in The Netherlands. Data on use and adherence was collected, in patients who were dispensed bupropion or varenicline in community pharmacies for the first time. Adherence was defined a using minimal 80% of the in guidelines recommended duration and intensity of use. Results: The study cohort consisted of 4,412 users of pSCT. The number of prescriptions was stable at 0.5 prescriptions per 1,000 inhabitants (dispensing prevalence, dp) during 2010. The prevalence was on average 0.8 dp, with peaks in the the 1 st and 4 th quarters of 2011. In 2012, the prevalence was stable at 0.4 dp. In 2013 was on average 0.5 dp, with a small peak in the 1 st quarter. Adherence was 18% in 2010 and 2012 (non-reimbursement period), and 21% in 2011 and 2013 (reimbursement period). ConClusions: Not only the likelihood of starting smoking cessation, but also the extent of adherence to pharmacologic smoking cessation is higher during reimbursement. Increasing the awareness of health care providers on adherence issues is warranted.